Scotiabank Initiates Disc Medicine at Sector Outperform
Disc Medicine Announces Presentation of New Data From Phase 1b Trial of DISC-0974 in Patients With Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
Express News | Disc Medicine Announces Presentation of New Data From Phase 1B Trial of Disc-0974 in Patients With Chronic Kidney Disease (Ckd) and Anemia at 2024 American Society of Nephrology (Asn) Kidney Week
Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald
Express News | Disc Medicine Expands Leadership Team With Appointment of Industry Veteran Steve Caffé, Md as Chief Regulatory Officer
Press Release: Disc Medicine Expands Leadership Team With Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer